Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 65 of 65 entries
Sorted by: Best Match Show Resources per page
Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-accordant Meta-analysis".

Annals of surgery

Onerup A, Angenete E, Haglind E.
PMID: 34784680
Ann Surg. 2021 Dec 01;274(6):e932. doi: 10.1097/SLA.0000000000005090.

No abstract available.

Cite
Onerup A, Angenete E, Haglind E. Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-accordant Meta-analysis". Ann Surg. 2021;274(6):e932doi: 10.1097/SLA.0000000000005090.
Onerup, A., Angenete, E., & Haglind, E. (2021). Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-accordant Meta-analysis". Annals of surgery, 274(6), e932. https://doi.org/10.1097/SLA.0000000000005090
Onerup, Aron, et al. "Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-accordant Meta-analysis"." Annals of surgery vol. 274,6 (2021): e932. doi: https://doi.org/10.1097/SLA.0000000000005090
Onerup A, Angenete E, Haglind E. Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-accordant Meta-analysis". Ann Surg. 2021 Dec 01;274(6):e932. doi: 10.1097/SLA.0000000000005090. PMID: 34784680.
Copy Download .nbib Format: NLM
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.

Cancer cell

Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG.
PMID: 34520734
Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13.

The CDK4/6 inhibitor, palbociclib (PAL), significantly improves progression-free survival in HR

Cite
Freeman-Cook K, Hoffman RL, Miller N, et al. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer Cell. 2021;39(10):1404-1421.e11doi: 10.1016/j.ccell.2021.08.009.
Freeman-Cook, K., Hoffman, R. L., Miller, N., Almaden, J., Chionis, J., Zhang, Q., Eisele, K., Liu, C., Zhang, C., Huser, N., Nguyen, L., Costa-Jones, C., Niessen, S., Carelli, J., Lapek, J., Weinrich, S. L., Wei, P., McMillan, E., Wilson, E., Wang, T. S., McTigue, M., Ferre, R. A., He, Y. A., Ninkovic, S., Behenna, D., Tran, K. T., Sutton, S., Nagata, A., Ornelas, M. A., Kephart, S. E., Zehnder, L. R., Murray, B., Xu, M., Solowiej, J. E., Visswanathan, R., Boras, B., Looper, D., Lee, N., Bienkowska, J. R., Zhu, Z., Kan, Z., Ding, Y., Mu, X. J., Oderup, C., Salek-Ardakani, S., White, M. A., VanArsdale, T., & Dann, S. G. (2021). Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer cell, 39(10), 1404-1421.e11. https://doi.org/10.1016/j.ccell.2021.08.009
Freeman-Cook, Kevin, et al. "Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor." Cancer cell vol. 39,10 (2021): 1404-1421.e11. doi: https://doi.org/10.1016/j.ccell.2021.08.009
Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13. PMID: 34520734.
Copy Download .nbib Format: NLM
Extended measuring depth dual-wavelength Fourier domain optical coherence tomography.

Biomedizinische Technik. Biomedical engineering

Al-Mohamedi H, Kelly-Pérez I, Oltrup T, Cayless A, Bende T.
PMID: 34087968
Biomed Tech (Berl). 2021 Jun 07;66(6):557-562. doi: 10.1515/bmt-2020-0350. Print 2021 Dec 20.

In this work an enhanced wide range dual band spectral domain optical coherence tomography technique (SD-OCT) is presented to increase the depth and accuracy of the measurement of optical A-scan biometry. The setup uses a Michelson interferometer with two...

Cite
Al-Mohamedi H, Kelly-Pérez I, Oltrup T, et al. Extended measuring depth dual-wavelength Fourier domain optical coherence tomography. Biomed Tech (Berl). 2021;66(6):557-562doi: 10.1515/bmt-2020-0350.
Al-Mohamedi, H., Kelly-Pérez, I., Oltrup, T., Cayless, A., & Bende, T. (2021). Extended measuring depth dual-wavelength Fourier domain optical coherence tomography. Biomedizinische Technik. Biomedical engineering, 66(6), 557-562. https://doi.org/10.1515/bmt-2020-0350
Al-Mohamedi, Haroun, et al. "Extended measuring depth dual-wavelength Fourier domain optical coherence tomography." Biomedizinische Technik. Biomedical engineering vol. 66,6 (2021): 557-562. doi: https://doi.org/10.1515/bmt-2020-0350
Al-Mohamedi H, Kelly-Pérez I, Oltrup T, Cayless A, Bende T. Extended measuring depth dual-wavelength Fourier domain optical coherence tomography. Biomed Tech (Berl). 2021 Jun 07;66(6):557-562. doi: 10.1515/bmt-2020-0350. Print 2021 Dec 20. PMID: 34087968.
Copy Download .nbib Format: NLM
Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial.

Annals of surgery

Onerup A, Andersson J, Angenete E, Bock D, Börjesson M, Ehrencrona C, Olsén MF, Larsson PA, de la Croix H, Wedin A, Haglind E.
PMID: 33843798
Ann Surg. 2021 Apr 09; doi: 10.1097/SLA.0000000000004901. Epub 2021 Apr 09.

OBJECTIVE: To determine the effect of a short-term, unsupervised exercise intervention before and after colorectal cancer surgery on self-assessed physical recovery.SUMMARY BACKGROUND DATA: Preoperative exercise interventions could help improve recovery after colorectal cancer surgery and is currently recommended.METHODS: A...

Cite
Onerup A, Andersson J, Angenete E, et al. Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial. Ann Surg. 2021;doi: 10.1097/SLA.0000000000004901.
Onerup, A., Andersson, J., Angenete, E., Bock, D., Börjesson, M., Ehrencrona, C., Olsén, M. F., Larsson, P. A., de la Croix, H., Wedin, A., & Haglind, E. (2021). Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000004901
Onerup, Aron, et al. "Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000004901
Onerup A, Andersson J, Angenete E, Bock D, Börjesson M, Ehrencrona C, Olsén MF, Larsson PA, de la Croix H, Wedin A, Haglind E. Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial. Ann Surg. 2021 Apr 09; doi: 10.1097/SLA.0000000000004901. Epub 2021 Apr 09. PMID: 33843798.
Copy Download .nbib Format: NLM
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.

Cancer cell

Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG.
PMID: 34520734
Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13.

The CDK4/6 inhibitor, palbociclib (PAL), significantly improves progression-free survival in HR

Cite
Freeman-Cook K, Hoffman RL, Miller N, et al. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer Cell. 2021;39(10):1404-1421.e11doi: 10.1016/j.ccell.2021.08.009.
Freeman-Cook, K., Hoffman, R. L., Miller, N., Almaden, J., Chionis, J., Zhang, Q., Eisele, K., Liu, C., Zhang, C., Huser, N., Nguyen, L., Costa-Jones, C., Niessen, S., Carelli, J., Lapek, J., Weinrich, S. L., Wei, P., McMillan, E., Wilson, E., Wang, T. S., McTigue, M., Ferre, R. A., He, Y. A., Ninkovic, S., Behenna, D., Tran, K. T., Sutton, S., Nagata, A., Ornelas, M. A., Kephart, S. E., Zehnder, L. R., Murray, B., Xu, M., Solowiej, J. E., Visswanathan, R., Boras, B., Looper, D., Lee, N., Bienkowska, J. R., Zhu, Z., Kan, Z., Ding, Y., Mu, X. J., Oderup, C., Salek-Ardakani, S., White, M. A., VanArsdale, T., & Dann, S. G. (2021). Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer cell, 39(10), 1404-1421.e11. https://doi.org/10.1016/j.ccell.2021.08.009
Freeman-Cook, Kevin, et al. "Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor." Cancer cell vol. 39,10 (2021): 1404-1421.e11. doi: https://doi.org/10.1016/j.ccell.2021.08.009
Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13. PMID: 34520734.
Copy Download .nbib Format: NLM
Showing 61 to 65 of 65 entries